The Guardian USLean left
← All coverage gaps
2026-10-13 18:32
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
25%75%
4 outlets · Left 1 · Center 3 · Right 0
How each side titled it
No right-side outlet ran this
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by CNBC (Center); 4 outlets over 4h.
CNBC · +2h UPI · +3h The Guardian US · +4h The Hill
What each side is saying
- The Guardian USLean left
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on…
Read at theguardian.com → - The HillCenter
The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for "flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical industry. In a court filing in the U.S.
Read at thehill.com → - UPICenter
Martin Shkreli faces contempt of court because he allegedly violated a 2022 court order banning him from the pharmaceutical industry.
Read at upi.com → - CNBCCenter
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
Read at cnbc.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
4 articles, newest first · filter by side
The HillCenter
FTC: 'Pharma bro' Shkreli violated lifetime industry ban, should be held in contempt
Read at thehill.com →The Guardian USLean left
FTC and seven states seek contempt ruling against Shkreli over pharma ban
Read at theguardian.com →UPICenter
FTC asks judge to find 'Pharma Bro' Martin Shkreli in contempt
Read at upi.com →CNBCCenter
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
Read at cnbc.com →Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.